Pfizer forecasts 2016 revenue, earnings below estimates

February 2, 2016 12:55 PM

3 0

Pfizer forecasts 2016 revenue, earnings below estimates

U.S. drugmaker Pfizer Inc (PFE.N), which is in the process of buying Botox-maker Allergan Plc (AGN.N) for $160 billion, forecast 2016 revenue and earnings below analysts' estimates, citing generic competition and a strong dollar.

The company said it expects reported revenue of $49 billion-$51 billion for the full year and adjusted earnings of $2.20-$2.30 per share.

Also read: Macau’s Four-Month Winning Streak Fuels Turnaround Hopes

Read more

To category page

Loading...